Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies

Supportive Care in Cancer

Volumn 14, Issue 7, 2006, Pages 783-786

  Grigull, Lorenz ^a   Beilken, Andreas ^a   Schmid, Hansjoerg ^a   Kirschner, P ^a   Sykora, Karl Walter ^a   Linderkamp, Christin ^a   Donnerstag, Frank ^a   Goudeva, Lilia ^a   Heuft, Hans Gert ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cancer; Childhood; Combination therapy; Fungal infection; Granulocyte transfusion

Indexed keywords

ANTIFUNGAL AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; CHILD; FUNGAL STRAIN; GRANULOCYTE TRANSFUSION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOTHERAPY; INFECTION CONTROL; MOULD; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKOCYTE TRANSFUSION; MALE; MUCORMYCOSIS; MYCOSES; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 33745090468     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0910-8     Document Type: Article

References (13)

1. Antachopoulos C, Walsh TJ (2005) New agents for invasive mycoses in children. Curr Opin Pediatr 17:78-87
2. Erdem I, Kucukercan M, Ceran N (2004) In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. Chemotherapy 49:294-297
3. Flynn TN, Kelsey SM, Hazel DL, Guest JF (1999) Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK. Pharmacoeconomics 16:543-550
4. Grigull L, Schrauder A, Schmitt-Thomssen A, Sykora K, Welte K (2002) Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection. Infection 30:267-271
5. Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T (2000) Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 26:759-762
6. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW (2004) Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 48:4574-4581
7. Kerr JP, Liakopolou E, Brown J, Cornish JM, Fleming D, Massey E, Oakhill A, Pamphilon DH, Robinson SP, Totem A, Valencia AM, Marks DI (2003) The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. Br J Haematol 123:114-118
8. Klastersky J (2004) Antifungal therapy in patients with fever and neutropenia - more rational and less empirical? N Engl J Med 351:1445-1447
9. Kontoyiannis DP, Lewis RE (2003) Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far. Drug Resist Updat 6:257-269
10. Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA (2005) Combination treatment of invasive fungal infections. Clin Microbiol Rev 18:163-194
11. Roilides E, Lyman CA, Panagopoulou P, Chanock S (2003) Immunomodulation of invasive fungal infections. Infect Dis Clin North Am 17:193-219
12. Torres HA, Kontoyiannis DP, Rolston KV (2004) High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer 12(7):511-516
13. Wiederhold NP, Lewis RE, Kontoyiannis DP (2003) Invasive aspergillosis in patients with hematologic malignancies. Pharmacotherapy 23:1592-1610